Common Contracts
4 similar Registration Rights Agreement contracts by Celsus Therapeutics Plc., Femasys Inc, PharmaCyte Biotech, Inc.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 16th, 2023 • PharmaCyte Biotech, Inc. • Biological products, (no disgnostic substances)
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of November 14, 2023, is by and among Femasys Inc., a Delaware corporation (the “Company”), and the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 15th, 2023 • Femasys Inc • Surgical & medical instruments & apparatus
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of November 14, 2023, is by and among Femasys Inc., a Delaware corporation (the “Company”), and the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 18th, 2023
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of February 8, 2019, is by and between Verus International, Inc., a Delaware corporation with offices located at 9841 Washingtonian Boulevard, #390, Gaithersburg, MD 20878 (the “Company”) and [ ] (the “Buyer”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 20th, 2013 • Celsus Therapeutics Plc. • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 19, 2013, is by and among Celsus Therapeutics Plc, a public limited company formed under the laws of England and Wales (the “Company”), and each of the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”).
